EUVIMEDEUVIMED entdecken
Open Access

Papillary thyroid carcinoma tall cell subtype ( PTC‐TC ) and high‐grade differentiated thyroid carcinoma tall cell phenotype ( HGDTC‐TC ) have different clinical behaviour: a retrospective study of 1456 patients

Ronald Ghossein, Nora Katabi, Snjezana Dogan iD, Ashok R Shaha, R Michael Tuttle, James A Fagin, Ian Ganly, Bin Xu iD

Histopathology · 2024-06 · 84 (7) · 1130-1138

DOI: 10.1111/his.15157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 25.03.2024. Verfasst von Ronald Ghossein und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Cancer, Papillary, Phenotype. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Papillary thyroid carcinoma, tall cell subtype (PTC‐TC) is a potentially aggressive histotype. The latest World Health Organisation (WHO) classification introduced a novel class of tumours; namely, high‐grade differentiated thyroid carcinoma (HGDTC), characterised by elevated mitotic count and/or necrosis, which can exhibit a tall cell phenotype (HGDTC‐TC). Methods and results We analysed the clinical outcomes in a large retrospective cohort of 1456 consecutive thyroid carcinomas with a tall cell phenotype, including PTC‐TC and HGDTC‐TC. HGDTC‐TC is uncommon, accounting for 5.3% (77 of 1379) of carcinomas with tall cell morphology. HGDTC‐TC was associated with significantly older age, larger tumour size, angioinvasion, gross extrathyroidal extension, higher AJCC pT stage, positive resection margin and nodal metastasis ( P < 0.05). Compared with PTC‐TC, HGDTC was associated with a significantly decreased DSS, LRDFS and distant metastasis‐free survival (DMFS; P < 0.001). The 10‐year DSS was 72 and 99%, the 10‐year LRDFS was 61 and 92% and the 10‐year DMFS was 53 and 97%, respectively, for HGDTC‐TC and PTC‐TC. On multivariate analysis, the classification (HGDTC‐TC versus PTC‐TC) was an independent adverse prognostic factor for DSS, LRDF, and DMFS when adjusted for sex, age, angioinvasion, margin status, AJCC pT and pN stage.

Conclusions

Compared with PTC‐TC, HGDTC‐TC is associated with adverse clinicopathological features, a higher frequency of TERT promoter mutations (59% in HGDTC‐TC versus 34% in PTC‐TC) and incurs a significantly worse prognosis. HGDTC‐TC is an independent prognostic factor for carcinoma with tall cell morphology. This validates the concept of HGDTC and the importance of tumour necrosis and high mitotic count for accurate diagnosis and prognosis of differentiated thyroid carcinomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid Cancer, PapillaryPhenotypeHumansMiddle AgedFemaleMaleRetrospective StudiesAdultAgedCarcinoma, PapillaryPrognosisYoung AdultAged, 80 and overAdolescentNeoplasm Grading

Stichwörter der Autor:innen

BRAF V600Ehigh‐grade differentiated thyroid carcinomapapillary thyroid carcinomaprognosistall cell subtype

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

ORCID-Profile: Snjezana Dogan, Bin Xu

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Ghossein, R., Katabi, N., Dogan, S., Shaha, A. R., Tuttle, R. M., Fagin, J. A., Ganly, I., & Xu, B. (2024). Papillary thyroid carcinoma tall cell subtype ( PTC‐TC ) and high‐grade differentiated thyroid carcinoma tall cell phenotype ( HGDTC‐TC ) have different clinical behaviour: a retrospective study of 1456 patients. Histopathology, 84(7), 1130-1138. https://doi.org/10.1111/his.15157

Vancouver

Ghossein R, Katabi N, Dogan S, Shaha AR, Tuttle RM, Fagin JA, et al. Papillary thyroid carcinoma tall cell subtype ( PTC‐TC ) and high‐grade differentiated thyroid carcinoma tall cell phenotype ( HGDTC‐TC ) have different clinical behaviour: a retrospective study of 1456 patients. Histopathology. 2024;84(7):1130-1138. doi:10.1111/his.15157

BibTeX
@article{Ghossein2024,
  author = {Ghossein, Ronald and Katabi, Nora and Dogan, Snjezana and Shaha, Ashok R and Tuttle, R Michael and Fagin, James A and Ganly, Ian and Xu, Bin},
  title = {Papillary thyroid carcinoma tall cell subtype ( PTC‐TC ) and high‐grade differentiated thyroid carcinoma tall cell phenotype ( HGDTC‐TC ) have different clinical behaviour: a retrospective study of 1456 patients},
  journal = {Histopathology},
  year = {2024},
  volume = {84},
  number = {7},
  pages = {1130--1138},
  doi = {10.1111/his.15157}
}
Kostenlos starten →